CVS Group plc (LON:CVSG)
London · Delayed Price · Currency is GBP · Price in GBX 1,234.00
+4.00 (0.33%)
Oct 15, 2026, 3:35 PM GMT
CVS Group Market Cap
CVS Group has a market cap or net worth of 835.91 million as of October 15, 2026. It is the 9,596th most valuable company in the world and the 225th biggest in the United Kingdom. Its market cap has decreased by 16.77% in one year.
Market Cap
835.91M
Enterprise Value
1.14B
Revenue
712.80M
Global Rank
Country Rank
#225 United Kingdom
PE Ratio
50.62
ChartMarket Cap Chart
Since October 10, 2007, CVS Group's market cap has increased from 4.71M to 835.91M, an increase of 17,636.61%. That is a compound annual growth rate of 31.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 835.91M | -7.93% |
| Dec 31, 2025 | 907.93M | 50.66% |
| Dec 31, 2024 | 602.62M | -49.95% |
| Dec 29, 2023 | 1.20B | -12.67% |
| Dec 30, 2022 | 1.38B | -13.16% |
| Dec 31, 2021 | 1.59B | 49.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 186.53B |
| GSK plc | 70.96B |
| Haleon | 31.25B |
| Smith & Nephew | 8.73B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.50B |
| Spire Healthcare Group | 989.48M |
| Oxford Biomedica | 647.56M |